Cruzipain, the Major Cysteine Protease of Trypanosoma cruzi: A Sulfated Glycoprotein Antigen as Relevant Candidate for Vaccine Development and Drug Target. A Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|24|3174-3202

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.24, 2009-08, pp. : 3174-3202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Major Cysteine Proteinase of Trypanosoma cruzi: A Valid Target for Chemotherapy of Chagas Disease

By  

Current Pharmaceutical Design, Vol. 7, Iss. 12, 2001-08 ,pp. : 1143-1156

Bentham Science Publishers

Access to resources Recommend Favorite

Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi

By  

Current Medicinal Chemistry, Vol. 22, Iss. 18, 2015-06 ,pp. : 2225-2235

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches for the Development of New Anti-Trypanosoma cruzi Agents

By  

Current Drug Targets, Vol. 10, Iss. 3, 2009-03 ,pp. : 212-231

Bentham Science Publishers

Access to resources Recommend Favorite

Trypanosoma cruzi Dihydrolipoamide Dehydrogenase as Target for Phenothiazine Cationic Radicals. Effect of Antioxidants

By  

Current Drug Targets, Vol. 7, Iss. 9, 2006-09 ,pp. : 1155-1179

Bentham Science Publishers

Access to resources Recommend Favorite

New Therapeutic Targets for Drug Design Against Trypanosoma cruzi, Advances and Perspectives

By  

Current Medicinal Chemistry, Vol. 16, Iss. 25, 2009-09 ,pp. : 3286-3293

Bentham Science Publishers

Access to resources Recommend Favorite